Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Id proteins at the cross-road of development and cancer

Abstract

A large body of evidence has been accumulated that demonstrates dominant effects of Id proteins on different aspects of cellular growth. Generally, constitutive expression of Id not only blocks cell differentiation but also drives proliferation. In some settings, it is sufficient to render cells immortal or induce oncogenic transformation. The participation of Id proteins in advanced human malignancy, where they are frequently deregulated, has been dramatically bolstered by the recent discovery that Id exert pivotal contributions to many of the essential alterations that collectively dictate malignant growth. Relentless proliferation associated with self-sufficiency in growth signals and insensitivity to growth inhibitory signals, sustained neoangiogenesis, tissue invasiveness and migration capabilities of tumor cells all share dependency on the unlimited availability of Id proteins. It is remarkable that many of these features recapitulate those physiologically propelled by Id proteins to support normal development. We propose that the participation of Id in multiple fundamental traits of cancer may be the basis for unprecedented therapeutic opportunities.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Munger K . 1999 Proc. Natl. Acad. Sci. USA 96: 9637–9641

  • Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC . 1996 Proc. Natl. Acad. Sci. USA 93: 13742–13747

  • Bain G, Cravatt CB, Loomans C, Alberola-Ila J, Hedrick SM, Murre C . 2001 Nat. Immunol. 2: 165–171

  • Barone MV, Pepperkok R, Peverali FA, Philipson L . 1994 Proc. Natl. Acad. Sci. USA 91: 4985–4988

  • Beger C, Pierce LN, Kruger M, Marcusson EG, Robbins JM, Welcsh P, Welch PJ, Welte K, King MC, Barber JR, Wong-Staal F . 2001 Proc. Natl. Acad. Sci. USA 98: 130–135

  • Belletti B, Prisco M, Morrione A, Valentinis B, Navarro M, Baserga R . 2001 J. Biol. Chem. 276: 13867–13874

  • Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H . 1990 Cell 61: 49–59

  • Chen CR, Kang Y, Massague J . 2001 Proc. Natl. Acad. Sci. USA 98: 992–999

  • Chen H, Weng YC, Schatteman GC, Sanders L, Christy RJ, Christy BA . 1999 Biochem. Biophys. Res. Commun. 256: 614–619

  • Christy BA, Sanders LK, Lau LF, Copeland NG, Jenkins NA, Nathans D . 1991 Proc. Natl. Acad. Sci. USA 88: 1815–1819

  • Cooper CL, Brady G, Bilia F, Iscove NN, Quesenberry PJ . 1997 Blood 89: 3155–3165

  • Deed RW, Hara E, Atherton GT, Peters G, Norton JD . 1997 Mol. Cell. Biol. 17: 6815–6821

  • Desprez PY, Hara E, Bissell MJ, Campisi J . 1995 Mol. Cell. Biol. 15: 3398–3404

  • Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ, Campisi J . 1998 Mol. Cell. Biol. 18: 4577–4588

  • Dyson N . 1998 Genes Dev. 12: 2245–2262

  • Evan GI, Vousden KH . 2001 Nature 411: 342–348

  • Florio M, Hernandez MC, Yang H, Shu HK, Cleveland JL, Israel MA . 1998 Mol. Cell. Biol. 18: 5435–5444

  • Grandori C, Cowley SM, James LP, Eisenman RN . 2000 Annu. Rev. Cell. Dev. Biol. 16: 653–699

  • Hanahan D, Weinberg RA . 2000 Cell 100: 57–70

  • Hara E, Hall M, Peters G . 1997 EMBO J. 16: 332–342

  • Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G . 1996 Mol. Cell. Biol. 16: 859–867

  • Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K . 1994 J. Biol. Chem. 269: 2139–2145

  • Iavarone A, Garg P, Lasorella A, Hsu J, Israel MA . 1994 Genes Dev. 8: 1270–1284

  • Ishiguro A, Spirin KS, Shiohara M, Tobler A, Gombart AF, Israel MA, Norton JD, Koeffler HP . 1996 Blood 87: 5225–5231

  • Israel MA, Hernandez MC, Florio M, Andres-Barquin PJ, Mantani A, Carter JH, Julin CM . 1999 Cancer Res. 59: 1726s–1730s

  • Jen Y, Manova K, Benezra R . 1997 Dev. Dyn. 208: 92–106

  • Katzenstein HM, Cohn SL . 1998 Curr. Opin. Oncol. 10: 43–51

  • Kebebew E, Treseler PA, Duh QY, Clark OH . 2000 Surgery 128: 952–957

  • Kee BL, Rivera RR, Murre C . 2001 Nat. Immunol. 2: 242–247

  • Kim D, Peng XC, Sun XH . 1999 Mol. Cell. Biol. 19: 8240–8253

  • Kleeff J, Ishiwata T, Friess H, Buchler MW, Israel MA, Korc M . 1998 Cancer Res. 58: 3769–3772

  • Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin Jr WG, Livingston DM . 1994 Cell 78: 161–172

  • Langlands K, Down GA, Kealey T . 2000 Cancer Res. 60: 5929–5933

  • Lasorella A, Iavarone A, Israel MA . 1996 Mol. Cell. Biol. 16: 2570–2578

  • Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A . 2000 Nature 407: 592–598

  • Lasorella A, Boldrini R, Dominici C, Donfrancesco A, Yokota Y, Inserra A, Iavarone A . 2002 Cancer Res. 62: in press

  • Lee EY, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, Herrup K . 1994 Genes Dev. 8: 2008–2021

  • Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, Desprez PY . 2000 Cancer Res. 60: 1332–1340

  • Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, Benezra R . 1999 Nature 401: 670–677

  • Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S . 2001 Nat. Med. 7: 1194–1201

  • Maris JM, Matthay KK . 1999 J. Clin. Oncol. 17: 2264

  • Martinsen BJ, Bronner-Fraser M . 1998 Science 281: 988–991

  • Maruyama H, Kleeff J, Wildi S, Friess H, Buchler MW, Israel MA, Korc M . 1999 Am. J. Pathol. 155: 815–822

  • Mori S, Nishikawa SI, Yokota Y . 2000 EMBO J. 19: 5772–5781

  • Morrow MA, Mayer EW, Perez CA, Adlam M, Siu G . 1999 Mol. Immunol. 36: 491–503

  • Nagata Y, Shoji W, Obinata M, Todokoro K . 1995 Biochem. Biophys. Res. Commun. 207: 916–926

  • Nagata Y, Todokoro K . 1994 Biochem. Biophys. Res. Commun. 199: 1355–1362

  • Neuman T, Keen A, Zuber MX, Kristjansson GI, Gruss P, Nornes HO . 1993 Dev. Biol. 160: 186–195

  • Nickoloff BJ, Chaturvedi V, Bacon P, Qin JZ, Denning MF, Diaz MO . 2000 J. Biol. Chem. 275: 27501–27504

  • Norton JD . 2000 J. Cell Sci. 113: 3897–3905

  • Norton JD, Atherton GT . 1998 Mol. Cell. Biol. 18: 2371–2381

  • Norton JD, Deed RW, Craggs G, Sablitzky F . 1998 Trends Cell Biol. 8: 58–65

  • Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E . 2001 Nature 409: 1067–1070

  • Polsky D, Young AZ, Busam KJ, Alani RM . 2001 Cancer Res. 61: 6008–6011

  • Roberts EC, Deed RW, Inoue T, Norton JD, Sharrocks AD . 2001 Mol. Cell. Biol. 21: 524–533

  • Sablitzky F, Moore A, Bromley M, Deed RW, Newton JS, Norton JD . 1998 Cell Growth Differ. 9: 1015–1024

  • Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P . 2001 Cancer Res. 61: 5703–5706

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Slack RS, El-Bizri H, Wong J, Belliveau DJ, Miller FD . 1998 J. Cell. Biol. 140: 1497–1509

  • Takai N, Miyazaki T, Fujisawa K, Nasu K, Miyakawa I . 2001 Cancer Lett. 165: 185–193

  • Toma JG, El-Bizri H, Barnabe-Heider F, Aloyz R, Miller FD . 2000 J. Neurosci. 20: 7648–7656

  • Walterhouse DO, Yoon JW . 1997 Cancer Treat. Res. 92: 3–38

  • Wang S, Sdrulla A, Johnson JE, Yokota Y, Barres BA . 2001 Neuron 29: 603–614

  • Weinberg RA . 1995 Cell 81: 323–330

  • Wice BM, Gordon JI . 1998 J. Biol. Chem. 273: 25310–25319

  • Yates PR, Atherton GT, Deed RW, Norton JD, Sharrocks AD . 1999 EMBO J. 18: 968–976

  • Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nichikawa S, Gruss P . 1999 Nature 397: 702–706

Download references

Acknowledgements

In preparing this review, we relied in part upon comprehensive reviews cited in the text and apologize for the omission of many important original references. Work in our laboratory is supported by NIH grant RO1-CA85628.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Iavarone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lasorella, A., Uo, T. & Iavarone, A. Id proteins at the cross-road of development and cancer. Oncogene 20, 8326–8333 (2001). https://doi.org/10.1038/sj.onc.1205093

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205093

Keywords

This article is cited by

Search

Quick links